We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
AUM
$1.95B
AUM Growth
-$51.1M
Cap. Flow
-$26M
Cap. Flow %
-1.33%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$10.1M

Top Sells

Rank Stock Value
1
QXO
QXO Inc
QXO
+$167M
2
SLDB icon
Solid Biosciences
SLDB
+$5.42M

Sector Composition

Rank Sector Weight
1 Industrials 21.33%
2 Energy 0.01%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$686M 35.13%
1,054,700
-518,500
-33% -$353M
SOXX icon
2
PUT
iShares Semiconductor ETF
SOXX
$43.4B
$483M 24.74%
+1,469,968
New +$502M
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$466B
$366M 18.76%
+634,755
New +$386M
QXO
4
QXO Inc
QXO
$14.9B
$269M 13.78%
13,858,415
-7,319,000
-35% -$167M
RXO icon
5
RXO
RXO
$4.83B
$147M 7.54%
10,073,618
+684,829
+7% +$10.1M
ANNAW
6
AleAnna Inc Warrant
ANNAW
$12.5M
$397K 0.02%
490,000
ANNA
7
AleAnna Inc
ANNA
$141M
$230K 0.01%
27,717
MNYWW
8
MoneyHero Ltd Warrants
MNYWW
$76.1K ﹤0.01%
895,000
CLDI icon
9
Calidi Biotherapeutics
CLDI
$2.3M
$249 ﹤0.01%
1,042
IWM icon
10
PUT
iShares Russell 2000 ETF
IWM
$82.2B
-1,617,000
Closed -$398M
SLDB icon
11
Solid Biosciences
SLDB
$858M
-961,251
Closed -$5.42M

Similar funds

Finepoint Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Finepoint Capital held 11 positions worth $1.95B, down 2.6% from $2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Finepoint Capital's Q1 2026 filing shows 2 new, 1 increased, 2 reduced and 2 closed positions. The largest sale was QXO Inc, an estimated $167M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 26% a quarter earlier, followed by Energy and Healthcare.

  • Finepoint Capital added most to RXO in Q1 2026, an estimated $10.1M increase.
  • Finepoint Capital's biggest Q1 2026 reduction was QXO Inc, cutting an estimated $167M.
  • Finepoint Capital fully exited Solid Biosciences in Q1 2026, selling an estimated $5.42M.
  • Finepoint Capital's ten largest holdings make up 100% of its $1.95B portfolio in Q1 2026.
  • Finepoint Capital opened 2 new positions and closed 2 in Q1 2026.
  • Finepoint Capital's portfolio value fell 2.6% quarter-over-quarter to $1.95B.

Based on Finepoint Capital's 13F filing for Q1 2026, filed 14 May 2026.